EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effectiveness of the Modified Vaccinia Ankara Vaccine Against Mpox in Men Who Have Sex With Men: A Retrospective Cohort Analysis, Seattle, Washington

Meena S Ramchandani iD, Anna Berzkalns, Chase A Cannon, Julia C Dombrowski iD, Elizabeth Brown, Eric J Chow, Elizabeth Barash, Sargis Pogosjans, Daniel Smith, Matthew R Golden

Open Forum Infectious Diseases · 01.11.2023 · 10 (11)

DOI: 10.1093/ofid/ofad528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 24.10.2023. Verfasst von Meena S Ramchandani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Washington, Seattle, Washington, USA. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Data on modified Vaccinia Ankara (MVA) vaccine effectiveness against mpox in real-world settings are limited.

Methods

We performed a retrospective cohort analysis using Cox proportional hazards regression to estimate the association between vaccination and laboratory-confirmed mpox incidence. Study subjects included all men who have sex with men seen in a sexual health clinic in Seattle, Washington, between 1 January 2020 and 31 December 2022. Subjects’ receipt of vaccine and diagnosis with mpox were ascertained from public health vaccine registry and surveillance data. Analyses were adjusted for demographic factors, human immunodeficiency virus (HIV) status, and sexual risk behaviors.

Results

The incidence of mpox per 100 person-years was 8.83 among patients with 0 doses, 3.32 among patients with 1 dose, and 0.78 among patients with 2 doses of MVA vaccine. Mpox diagnosis was significantly associated with age category 30–39 and 40–51 years, HIV positivity, syphilis diagnosis in the prior year, >10 sex partners in the last year, and having a clinic visit in the last year. In the multivariate model adjusting for these factors, vaccine effectiveness was 81% for 1 dose and 83% for 2 doses.

Conclusions

These data support the effectiveness of the MVA vaccine—including a single dose of the vaccine—in preventing mpox disease and highlight the appropriateness of risk factor-based prioritization of immunization early in the epidemic. The durability of MVA vaccine-induced immunity is unknown, and at-risk persons should receive 2 doses of MVA.

Schlagwörter

Stichwörter der Autor:innen

JYNNEOSMPXVMVAmodified vaccinia Ankarampox

Autor:innen und Institutionen

  • Department of Medicine, University of Washington, Seattle, Washington, USA.
  • HIV/STI/HCV Program, Public Health-Seattle & King County, Seattle, Washington, USA.
  • Department of Epidemiology, University of Washington, Seattle, Washington, USA.
  • Department of Biostatistics, University of Washington, Seattle, Washington, USA.
  • Communicable Disease Epidemiology and Immunizations, Public Health-Seattle & King County, Seattle, Washington, USA.

ORCID-Profile: Meena S Ramchandani, Julia C Dombrowski

Förderung

  • National Institute of Allergy and Infectious Diseases
  • National Cancer Institute
  • National Institute of Mental Health
  • National Institute on Drug Abuse
  • National Institute of Child Health and Human Development
  • National Heart, Lung, and Blood Institute
  • National Institute on Aging
  • National Institute of General Medical Sciences

Zitieren

APA

Ramchandani, M. S., Berzkalns, A., Cannon, C. A., Dombrowski, J. C., Brown, E., Chow, E. J., Barash, E., Pogosjans, S., Smith, D., & Golden, M. R. (2023). Effectiveness of the Modified Vaccinia Ankara Vaccine Against Mpox in Men Who Have Sex With Men: A Retrospective Cohort Analysis, Seattle, Washington. Open Forum Infectious Diseases, 10(11). https://doi.org/10.1093/ofid/ofad528

Vancouver

Ramchandani MS, Berzkalns A, Cannon CA, Dombrowski JC, Brown E, Chow EJ, et al. Effectiveness of the Modified Vaccinia Ankara Vaccine Against Mpox in Men Who Have Sex With Men: A Retrospective Cohort Analysis, Seattle, Washington. Open Forum Infectious Diseases. 2023;10(11). doi:10.1093/ofid/ofad528

BibTeX
@article{Ramchandani2023,
  author = {Ramchandani, Meena S and Berzkalns, Anna and Cannon, Chase A and Dombrowski, Julia C and Brown, Elizabeth and Chow, Eric J and Barash, Elizabeth and Pogosjans, Sargis and Smith, Daniel and Golden, Matthew R},
  title = {Effectiveness of the Modified Vaccinia Ankara Vaccine Against Mpox in Men Who Have Sex With Men: A Retrospective Cohort Analysis, Seattle, Washington},
  journal = {Open Forum Infectious Diseases},
  year = {2023},
  volume = {10},
  number = {11},
  doi = {10.1093/ofid/ofad528}
}
Kostenlos starten →